Compounds > tegafur
Page last updated: 2024-11-04

tegafur and Cardiomyopathies

tegafur has been researched along with Cardiomyopathies in 1 studies

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marcos Sánchez, F1
Albo Castaño, I1
Arbol Linde, F1
Juárez Ucelay, F1
Durán Pérez-Navarro, A1

Other Studies

1 other study available for tegafur and Cardiomyopathies

ArticleYear
[Cardiac toxicity and UFT].
    Anales de medicina interna (Madrid, Spain : 1984), 2003, Volume: 20, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Humans; Tegafur; Uracil

2003